Milestone Scientific (MLSS) Income from Non-Controlling Interests (2015 - 2023)
Milestone Scientific (MLSS) reported Income from Non-Controlling Interests of -$17856.0 for Q4 2023, down 40.54% on a YoY basis from -$30031.8 in Q4 2022, and down 82.0% sequentially from -$9811.0 in Q3 2023.
Milestone Scientific (MLSS) Income from Non-Controlling Interests (2015 - 2023) Analysis & Trends
Milestone Scientific (MLSS) has 9 years of Income from Non-Controlling Interests data on file, last reported at -$17856.0 in Q4 2023.
- For the quarter ending Q4 2023, Income from Non-Controlling Interests fell 40.54% year-over-year to -$17856.0; the trailing twelve-month figure through Sep 2024 stood at -$17856.0 (up 61.76% YoY), and the FY2023 full-year result was -$51843.0, up 22.32% from the prior year.
- Income from Non-Controlling Interests fell to -$17856.0 in Q4 2023, from -$9811.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$9811.0 in Q3 2023 to a low of -$22848.0 in Q2 2022.
- A 5-year average of -$14205.2 and a median of -$12839.5 in 2019 frame the typical range for Income from Non-Controlling Interests.
- Peak annual rise in Income from Non-Controlling Interests reached 89.7% in 2019, while the deepest fall reached 70.99% in 2019.
- Tracing MLSS's Income from Non-Controlling Interests over 5 years: stood at -$20529.0 in 2019, then climbed by 21.88% to -$16038.0 in 2020, then retreated by 3.35% to -$16575.0 in 2021, then climbed by 23.35% to -$12705.0 in 2022, then sank by 40.54% to -$17856.0 in 2023.
- Business Quant data shows MLSS's Income from Non-Controlling Interests at -$17856.0 in Q4 2023, -$9811.0 in Q3 2023, and -$12511.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -18.70 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 110.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Milestone Scientific | 33.00 Mn | 31.35 Mn | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -17,856.00 |
| Sep 30, 2023 | -9,811.00 |
| Jun 30, 2023 | -12,511.00 |
| Mar 31, 2023 | -11,665.00 |
| Dec 31, 2022 | -12,705.00 |
| Sep 30, 2022 | -13,680.00 |
| Jun 30, 2022 | -22,848.00 |
| Mar 31, 2022 | -17,502.00 |
| Dec 31, 2021 | -16,575.00 |
| Sep 30, 2021 | -12,227.00 |
| Jun 30, 2021 | -16,325.00 |
| Mar 31, 2021 | -12,988.00 |
| Dec 31, 2020 | -16,038.00 |
| Sep 30, 2020 | -11,025.00 |
| Jun 30, 2020 | -11,738.00 |
| Mar 31, 2020 | -12,738.00 |
| Dec 31, 2019 | -20,529.00 |
| Sep 30, 2019 | -12,941.00 |
| Jun 30, 2019 | -11,959.00 |
| Mar 31, 2019 | -10,443.00 |